Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arthritis & Rheumatism

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22052PMID 16947781
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The perception of rheumatoid arthritis core set measures by rheumatologists. Results of a survey.

  2006cited by this paper
• Duration of rheumatoid arthritis influences the degree of functional improvement in clinical trials

  2005cited by this paper
• The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis.

  2005cited by this paper
• A model of impairment and functional limitation in rheumatoid arthritis

  2005cited by this paper
• Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states.

  2005cited by this paper
• The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis.

  2004cited by this paper
• Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial.

  2004cited by this paper
• Radiological progression in established rheumatoid arthritis.

  2004cited by this paper
• Association between baseline radiographic damage and improvement in physical function after treatment of patients with rheumatoid arthritis

  2004cited by this paper
• Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

  2004cited by this paper
• Patients with rheumatoid arthritis in clinical care

  2004cited by this paper
• Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden

  2004cited by this paper
• Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial.

  2004cited by this paper
• Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

  2003cited by this paper
• A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

  2003cited by this paper
• The effects of disease-modifying anti-rheumatic drugs on the Health Assessment Questionnaire score. Lessons from the leflunomide clinical trials database.

  2002cited by this paper
• Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.

  2002cited by this paper
• Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine

  2001cited by this paper
• The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis.

  2001cited by this paper
• Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

  2000cited by this paper
• Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis

  2000cited by this paper
• A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis.

  2000cited by this paper
• The links between joint damage and disability in rheumatoid arthritis.

  2000cited by this paper
• Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time.

  1999cited by this paper
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

  1999cited by this paper
• Economic consequences of the progression of rheumatoid arthritis in Sweden.

  1999cited by this paper
• Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

  1999cited by this paper
• Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.

  1998cited by this paper
• Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants.

  1994cited by this paper
• Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.

  1989cited by this paper
• Long-term outcome of treating rheumatoid arthritis: results after 20 years.

  1987cited by this paper
• How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

  1985cited by this paper
• Measurement of patient outcome in arthritis.

  1980cited by this paper
• Letter: Moorgate tube disaster: disputed alcohol findings.

  1975cited by this paper

• Maintaining clinical remission and preventing fractures are essential for preserving functional status over a 10-year period in patients with rheumatoid arthritis who have achieved Health Assessment Questionnaire-Disability Index remission: a retrospective cohort study.

  2026cites this paper
• Structural and Functional Outcomes in Rheumatoid Arthritis After 10-Year Therapy with Disease-Modifying Antirheumatic Drugs Under Tight Control: Evidence from Real-World Cohort Data

  2025cites this paper
• Ultrasonographic measurement of talar cartilage thickness in patients with rheumatoid arthritis and healthy controls

  2025cites this paper
• Patients’ Experiences Following Osteoarticular Foot Surgery for Rheumatoid Arthritis-Related Deformities: A Qualitative Study

  2025cites this paper
• Asthma remission in the context of other immune-mediated diseases.

  2025cites this paper
• CD5L insufficiency exacerbates skeletal joint damage in rheumatoid arthritis

  2025cites this paper
• Impact of Foot Surgery and Pharmacological Treatments on Functionality and Pain in Rheumatoid Arthritis: A Five-Year Longitudinal Study

  2025cites this paper
• Determining patient acceptable symptom states from patient reported outcome measures following reverse shoulder arthroplasty: Constant-murley, UCLA, Oxford Shoulder Scores.

  2024cites this paper
• Molecular and cellular contributors of Rheumatoid Arthritis

  2024cites this paper
• Increased Risk of New-Onset Rheumatoid Arthritis Among Osteoarthritis Patients Received Total Knee Arthroplasty: a global federated health network analysis

  2024cites this paper
• The effective threshold dose of etanercept in patients with methotrexate-resistant rheumatoid arthritis

  2023influential citation
• The Adaption and Validation Processes in Remission Criteria for Rheumatoid Arthritis

  2023cites this paper
• Rheumatoid arthritis molecular targets and their importance to flavonoid‐based therapy

  2023cites this paper
• Changes in Physical Function using Three Methods of Scoring the Health Assessment Questionnaire in Established Active Rheumatoid Arthritis

  2023cites this paper
• Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial

  2023cites this paper
• An engineered glove to follow finger function in rheumatoid arthritis: an observational prospective study

  2023cites this paper
• Exploring the disparity between inflammation and disability in the 10-year outcomes of people with rheumatoid arthritis

  2022cites this paper
• Rheumatoid arthritis: advances in treatment strategies

  2022cites this paper
• Validation of the Simplified Disease Activity Index (SDAI) with a quick quantitative C-reactive protein assay (SDAI-Q) in patients with rheumatoid arthritis: a prospective multicenter cross-sectional study

  2022cites this paper
• Harpagoside attenuates local bone Erosion and systemic osteoporosis in collagen-induced arthritis in mice

  2022cites this paper
• The impact of diabetes mellitus on treatment and outcomes of rheumatoid arthritis at 5-year follow-up: results from a multi-ethnic Asian cohort

  2021cites this paper
• Trajectory clusters of radiographic progression in patients with rheumatoid arthritis: associations with clinical variables

  2021cites this paper
• Engineered glove to evaluate hand disability in rheumatoid arthritis: a pilot-study.

  2021cites this paper
• The impact of time length to Boolean remission for tight disease activity control after acquisition in rheumatoid arthritis patients

  2021cites this paper
• Study of serum adenosine deaminase -2 (ADA-2) activity in rheumatoid arthritis

  2021cites this paper
• DEFICITUL FUNCŢIONAL MOTOR ÎN SPONDILOARTRITA ANCHILOZANTĂ: VALOAREA ACTIVITĂŢII BOLII ȘI A MODIFICĂRILOR RADIOLOGICE

  2021cites this paper
• Evaluation of Adenosine deaminase, Serum C-reactive protein and alkaline phosphatase activity in Rheumatoid Arthritis patients in Shivamogga district, South India

  2020influential citation
• An overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions.

  2020cites this paper
• Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis

  2020cites this paper
• Insights into the treatment of rheumatoid arthritis: A paradigm in medicine.

  2020cites this paper
• Disease Modifying Anti Rheumatic Drugs in Sudanese Patients with Rheumatoid Arthritis

  2020influential citation
• Use of multidimensional composite scores in rheumatology: parsimony versus subtlety

  2020cites this paper
• Health Assessment Questionnaire at One Year Predicts All‐Cause Mortality in Patients With Early Rheumatoid Arthritis

  2020cites this paper
• Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis

  2020cites this paper
• Real - rheumatoid arthritis in real life - study cohort: a sociodemographic profile of rheumatoid arthritis in Brazil

  2020cites this paper
• Clinical conditions needed to acquire sustained functional remission in rheumatoid arthritis patients

  2020cites this paper
• Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?

  2019cites this paper
• A Longitudinal Study of the 28 Joints of Disease Activity Score by Ultrasonographical Examination in Rheumatoid Arthritis Patients

  2019cites this paper
• Treat to Target in Rheumatology: A Historical Account on Occasion of the 10th Anniversary.

  2019cites this paper
• Use of a “critical difference” statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis

  2019cites this paper
• On Needles and Haystacks: The Perils of Cardiovascular Risk Screening in Rheumatoid Arthritis

  2019cites this paper
• Prevention of the progressive biochemical cartilage destruction under methotrexate therapy in early rheumatoid arthritis.

  2019cites this paper
• Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies

  2019cites this paper
• Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

  2019cites this paper
• A comparison of thermographic characteristics of the hands and wrists of rheumatoid arthritis patients and healthy controls

  2019cites this paper
• OP-RAPC170019 1..8

  2018cites this paper
• Defining refractory rheumatoid arthritis

  2018cites this paper
• Dickkopf 1 protein circulating levels as a possible biomarker of functional disability and chronic damage in patients with rheumatoid arthritis

  2018cites this paper
• Strategies toward rheumatoid arthritis therapy; the old and the new

  2018cites this paper
• Contribution of the bone and cartilage/soft tissue components of the joint damage to the level of disability in rheumatoid arthritis patients: a longitudinal study

  2018cites this paper
• Susceptibility-weighted MR imaging to improve the specificity of erosion detection: a prospective feasibility study in hand arthritis

  2018cites this paper
• Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis

  2018cites this paper
• Rapid onset of efficacy predicts response to therapy with certolizumab plus methotrexate in patients with active rheumatoid arthritis

  2018cites this paper
• Rheumatoid arthritis

  2018cites this paper
• Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan

  2018cites this paper
• Disease activity assessment in patients with psoriatic arthritis.

  2018cites this paper
• Impact of patient-reported flares on radiographic progression and functional impairment in patients with rheumatoid arthritis: a cohort study based on the AMBRA trial

  2018cites this paper
• Планирование регистрационной программы исследований препаратов базисной противовоспалительной терапии ревматоидного артрита

  2018cites this paper
• Tetrandrine attenuates the bone erosion in collagen‐induced arthritis rats by inhibiting osteoclastogenesis via spleen tyrosine kinase

  2018cites this paper
• CORRELATION OF ROUTINE ASSESSMENT OF PATIENT INDEX DATA3 SCORE (RAPID3) WITH DISEASE ACTIVITY SCORE 28 (DAS28) AND HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) IN PATIENTS WITH RHEUMATOID AND PSORIATIC ARTHRITIS – OUR EXPERIENCE

  2018cites this paper
• EXPLORING THE RELATIONSHIP BETWEEN IMPAIRMENT AND DISABILITY IN INDIVIDUALS WITH RHEUMATOID ARTHRITIS

  2018cites this paper
• Romatoid Artritli Hastalarda Erozyon Şiddeti Fonksiyonel Durumun Belirleyicisi Olabilir Mi

  2018cites this paper
• IL-6 is an independent predictive factor of drug survival after dose escalation of infliximab in patients with rheumatoid arthritis

  2018cites this paper
• Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study

  2017cites this paper
• Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.

  2017cites this paper
• Curative remedies for rheumatoid arthritis: Herbal informatics approach for rational based selection of natural plant products

  2017cites this paper
• RÔLE DE POLYMORPHISMES NUCLÉOTIDIQUES DANS LES GÈNESDE L’INTERLEUKINE-4 ET SON RÉCEPTEUR ET DU CORÉCEPTEURCD40, ET DES ALLÈLES HLA-DR, DANS LA PROGRESSION DE LAPOLYARTHRITE INFLAMMATOIRE D’INSTALLATION RÉCENTE

  2017cites this paper
• The UltraSound-CLinical ARthritis Activity (US-CLARA) index: Properties of a new composite disease activity index for rheumatoid arthritis.

  2017cites this paper
• The effects of structural damage on functional disability in psoriatic arthritis

  2017cites this paper
• Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone

  2017cites this paper
• Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

  2017cites this paper
• Editorial Board Research Misconduct

  2017cites this paper
• Long-Term Effectiveness of Adalimumab in Patients with Rheumatoid Arthritis: An Observational Analysis from the Corrona Rheumatoid Arthritis Registry

  2017cites this paper
• Patient’s perspective of sustained remission in rheumatoid arthritis

  2017cites this paper
• Anti-citrullinated peptide antibodies are the strongest predictor of clinically relevant radiographic progression in rheumatoid arthritis patients achieving remission or low disease activity: A post hoc analysis of a nationwide cohort in Japan

  2017cites this paper
• Bioethical challenges to rheumatology in resource poor areas: a review

  2017cites this paper
• The minimally important difference for the Japanese version of the health assessment questionnaire in patients with rheumatoid arthritis in daily practice

  2017cites this paper
• The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis – a cohort study

  2017cites this paper
• Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity

  2017cites this paper
• The 8-foot up and go test is the best way to assess physical function in the rheumatoid arthritis clinic

  2017cites this paper
• The Use of MDHAQ/RAPID3 in Different Rheumatic Diseases A Review of the Literature.

  2017cites this paper
• Continual Maintenance of Remission Defined by the ACR/EULAR Criteria in Daily Practice Leads to Better Functional Outcomes in Patients with Rheumatoid Arthritis

  2017cites this paper
• Predicting and monitoring disease course in rheumatoid arthritis : imaging, biomarkers, risk factors, and integrative medicine

  2017cites this paper
• Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5‐year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan

  2016cites this paper
• Changes in foot function, disease activity, and disability after forefoot resection arthroplasty in patients with rheumatoid arthritis.

  2016cites this paper
• Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study

  2016cites this paper
• Rheumatoid arthritis : the influence of disease activity on clinical and serological parameters

  2016cites this paper
• Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.

  2016cites this paper
• Factor , Anticitrullinated Protein Antibodies , or Radiographic Erosions other Core Data Set Measures , but Not by the Absence of Rheumatoid Prediction of Remission in a French Early Arthritis Cohort by RAPID 3 and and

  2016cites this paper
• Information technology concerning SDAI and CDAI.

  2016cites this paper
• Prognostic Factors Toward Clinically Relevant Radiographic Progression in Patients With Rheumatoid Arthritis in Clinical Practice

  2016cites this paper
• Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON)

  2016cites this paper
• THU0206 Post-Marketing Surveillance of Efficacy and Safety of Tacrolimus Add-on Therapy in Japanese Rheumatoid Arthritis Patients without An Adequate Response To Biological dMARDs

  2016cites this paper
• Assessment of Adenosine Deaminase and Total Antioxidant of Rheumatoid Arthritis Patients in Hilla City

  2016cites this paper
• Association of the different types of radiographic damage with physical function in patients with rheumatoid arthritis: analysis of the RAPID trials

  2016cites this paper
• Prediction of Remission in a French Early Arthritis Cohort by RAPID3 and other Core Data Set Measures, but Not by the Absence of Rheumatoid Factor, Anticitrullinated Protein Antibodies, or Radiographic Erosions

  2016cites this paper
• Cerebrovascular dysfunction in the presence of chronic inflammation

  2016cites this paper
• Knorpelqualität der Fingergelenke bei früher rheumatoider Arthritis: delayed Gd(DTPA)2– enhanced MRI of the cartilage (dGEMRIC) im frühen therapienaiven Zustand und im Verlauf unter Therapie

  2016influential citation
• Cartilage damage and bone erosion are more prominent determinants of functional impairment in longstanding experimental arthritis than synovial inflammation

  2016cites this paper
• Control treatments in biologics trials of rheumatoid arthritis were often not deemed acceptable in the context of care.

  2016cites this paper